Ajax-Loading

AbbVie Inc - Ebitda Per Share

AbbVie Inc's Fiscal Year is From January To December - All Figures are in USD.

The item "Ebitda-Per-Share" stands at 7.48 United States Dollars as of 09/30/2025, the lowest value at least since 06/30/2022, the period currently displayed.

As of the end of AbbVie Inc's third quarter, the item "Ebitda Per Share" stands at 7.48 USD. This represents a decrease of -8.45 percent compared to it's value at the end of it's second quarter .


Regarding the One-Year-Change of the series, the current value constitutes a decrease of -28.56 percent compared to the value the year prior.
The 1 year change in percent is -28.56.
The 3 year change in percent is -44.55.

The Serie's long term average value is 10.85 United States Dollars. It's latest available value, on 09/30/2025, is 31.08 percent lower, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 09/30/2025, to it's latest available value, on 09/30/2025, is +0.0%.
The Serie's change in percent from it's maximum value, on 03/31/2022, to it's latest available value, on 09/30/2025, is -46.12%.

Ebitda Per Share for Related Companies:

LogoNameMarket Cap (USD)
LogoEli Lilly and Company - Ebitda Per Share905,699,262,464.00
LogoJohnson & Johnson - Ebitda Per Share486,508,953,600.00
LogoRoche Holding AG - Ebitda Per Share317,433,206,677.55
LogoAstraZeneca PLC - Ebitda Per Share280,205,508,085.11
LogoNovartis AG - Ebitda Per Share255,096,620,580.91